Corvus Pharmaceuticals Cash from Discontinued Operations Adjustment (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

17.82 +0.61 (+3.54%) USD | NASDAQ | Feb 24, 16:00

17.82 0.00 (0.00%) After-Hours: 20:00

View Cash from Discontinued Operations Adjustment (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Discontinued Operations Adjustment (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Plus Therapeutics, Inc.	--
Geron Corp.	--
Jaguar Health, Inc.	--
Krystal Biotech, Inc.	--